Atrophy: Clinical Trials

2 trials for Atrophy, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

2 terminated. 2 Phase 4.

By phase and status

PhaseTrialsStatus
Phase 42Terminated 2

Follow Atrophy: new trials by email Literature Review of Atrophy trials Research Report on Atrophy

Trials (filtered) newest first · largest first

All 2 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Effects of a Supplement Enriched in Hydroxymethylbutyrate and Vitamin D on Muscle Strength in Hip Fracture
Supplement with HMB and vitamin D, Standard nutritional supplement - Hip Fractures
Phase 4TerminatedHospital Clinic of Barcelona22013-06-012015-08-19
TOM: Testosterone in Older Men With Sarcopenia
Topical testosterone gel 1% (active formulation), Topical gel (placebo formulation) - Sarcopenia, Hypogonadism
Phase 4TerminatedBoston Medical Center2092005-01-012017-02-23

Narrower conditions

Sarcopenia (2)  ·  Frailty (1)  ·  Hip Fractures (1)  ·  Hypogonadism (1)  ·  Muscular Diseases (1)

Broader conditions

Muscular Atrophy (2)  ·  Nervous System Diseases (2)  ·  Neurologic Manifestations (2)  ·  Neuromuscular Manifestations (2)  ·  Pathological Conditions, Anatomical (2)  ·  Pathological Conditions, Signs and Symptoms (2)  ·  Signs and Symptoms (2)  ·  Endocrine System Diseases (1)  ·  Femoral Fractures (1)  ·  Fractures, Bone (1)  ·  Gonadal Disorders (1)  ·  Hip Injuries (1)  ·  Leg Injuries (1)  ·  Musculoskeletal Diseases (1)

Interventions

Gels (1)  ·  Testosterone (1)  ·  Vitamin D (1)

Sponsors

Boston Medical Center (1)  ·  Hospital Clinic of Barcelona (1)

Countries

Spain (1)  ·  United States (1)

Top investigators

Joan Trabal, RD, MS (1)  ·  Margarita Navarro, MD (1)  ·  Maria T Forga, MD (1)  ·  Pere Leyes, MD (1)  ·  Salvi Prat, MD, PhD (1)  ·  Shalender Bhasin, MD (1)  ·  Shehzad Basaria, MD (1)  ·  Wildon Farwell, MD, MPH (1)

Results publications

PMID 18996225, PMID 20592293, PMID 21697501, PMID 23292288, PMID 28950424, PMID 28981994, PMID 29846604, PMID 38224135

NIH funding

U01AG014369 (1)